Individuals carrying gPVs in MLH1 and MSH2 showed significantly higher cumulative lifetime incidences of CRC compared to those with MSH6 gPVs (p < 0.001; p = 0.021; Fig. 2). This evidence concerns the gene MLH1 and colorectal carcinoma.